Calendar PolyPeptide Group AG London S.E.

Equities

0AAJ

CH1110760852

Market Closed - London S.E. 05:29:00 07/05/2024 pm IST 5-day change 1st Jan Change
31.25 CHF +90.20% Intraday chart for PolyPeptide Group AG -3.25% +78.37%

Chart calendar PolyPeptide Group AG

5a13952c2.KFI2hqROYuCkjVAmSfe13pFSnihLyu7lwTi3y8veE58.Rg1XtOocOqXW4Q9cI77hvek3r2k6gYKzsXbuuIq7J-tYIl23nQs6pPbjPw~cfb872f61473ad3391fdff7e5eba7b8a

Upcoming events on PolyPeptide Group AG

13/08/2024 Q2 2024 Earnings Call
13/08/2024 Q2 2024 Earnings Release Pre-market
11/03/2025 Q4 2024 Earnings Call
11/03/2025 Q4 2024 Earnings Release
09/04/2025 Annual General Meeting
12/08/2025 Q2 2025 Earnings Call
12/08/2025 Q2 2025 Earnings Release
17/03/2026 Q4 2025 Earnings Release (Projected)
18/08/2026 Q2 2026 Earnings Release (Projected)
16/03/2027 Q4 2026 Earnings Release (Projected)
17/08/2027 Q2 2027 Earnings Release (Projected)

Past events on PolyPeptide Group AG

10/04/2024 07:30 pm Annual General Meeting
12/03/2024 03:00 pm Q4 2023 Earnings Call
12/03/2024 11:15 am Q4 2023 Earnings Release
29/11/2023 Nordic Life Science Days
30/10/2023 TIDES Europe Conference
24/10/2023 CPHI Conference
16/10/2023 Peptide Therapeutics Symposium
18/09/2023 Boulder Peptide Symposium
17/09/2023 Groupe Français des Peptides et Protéines Meeting
06/09/2023 RNA Leaders Congress
15/08/2023 01:00 pm Q2 2023 Earnings Call
15/08/2023 10:30 am Q2 2023 Earnings Release
13/07/2023 01:00 pm Q2 2023 Sales and Revenue Call
13/07/2023 10:30 am Q2 2023 Sales and Revenue Release
24/04/2023 Swiss Biotech Day
14/04/2023 American Association for Cancer Research Meeting
12/04/2023 07:30 pm Annual General Meeting
30/03/2023 Biologics UK Conference
20/03/2023 BIO Europe Spring
15/03/2023 RNA Leaders Europe Congress

Past dividends on PolyPeptide Group AG

28/04/2022 Other Dividend 0.3 CHF

Annual results

Fiscal PeriodDecember 2020 2021 2022 2023 2024
Net sales
Million EUR
Released
Forecast
Spread
223


282
276
2.13%
281
285
-1.41%
325
294
10.39%

349

EBITDA
Million EUR
Released
Forecast
Spread
0,00


84,8
89,4
-5.11%
38,7
43,1
-10.32%
-6,00
-5,57
-7.68%

27,4

EBIT
Million EUR
Released
Forecast
Spread
0,00


64,2
68,9
-6.8%
12,6
19,4
-34.87%
-36,5
-36,9
1.05%

-4,09

Earnings before Tax (EBT)
Million EUR
Released
Forecast
Spread
0,00


59,8
66,5
-10%
7,57
16,3
-53.67%
-58,2
-44,1
-32.22%

-12,6

Net income
Million EUR
Released
Forecast
Spread
31,3


47,3
54,6
-13.37%
7,77
13,3
-41.81%
-51,4
-36,6
-40.73%

-12,2

EPS
EUR
Released
Forecast
Spread
0,00


1,47
1,66
-11.66%
0,24
0,41
-41.1%
-1,56
-1,05
-48.99%

-0,26

Announcement Date15/03/2115/03/2214/03/2312/03/24-

Quarterly results

Fiscal PeriodDecember 2021 S1 2022 S1 2022 S2 2023 S1 2023 S2 2024 S1 2024 S2
Net sales
Million EUR
Released
Forecast
Spread
135


134
138
-3.26%
147
151
-2.69%
132
126
4.44%
191
167
14.37%

132


213

EBITDA
Million EUR
Released
Forecast
Spread
39,9


26,7
28,1
-4.99%



-19,4
-5,50
-252.49%
13,4
13,9
-3.74%

0,70


26,8

EBIT
Million EUR
Released
Forecast
Spread



15,5
15,5
-0.08%




-37,3

-2,00
-2,54
21.1%

-14,9


10,7

Net income
Million EUR
Released
Forecast
Spread



10,2
11,8
-13.16%
-2,48
1,90
-230.53%
-34,3
-44,9
23.68%




-19,8


8,70

EPS
EUR
Released
Forecast
Spread



0,31
0,36
-12.68%



-1,04
-1,36
23.53%









Announcement Date17/08/2118/08/2214/03/2315/08/2312/03/24--

Net sales - Quarter - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. PPGN Stock
  4. 0AAJ Stock
  5. Calendar PolyPeptide Group AG